Table 4.
Preparation (pH 5.0) | Injection dosage of TUDCA (mg/kg) | Death rate (%) | Survival time (min) | State |
---|---|---|---|---|
NK | 0 | 100 | 1, 1, 1 | ccc |
NK-TUDCA (TUDCA: 1 mg/ml) | 13 | 100 | 2, 2, 4 | ccc |
NK-TUDCA (TUDCA: 5 mg/ml) | 65 | 0 | a, a, a | bbb |
NK-TUDCA (TUDCA: 10 mg/ml) | 130 | 0 | a, a, a | bbb |
NK-TUDCA (TUDCA: 15 mg/ml) | 195 | 0 | a, a, a | bbb |
The mouse was not dead within 48 h after injection.
The mouse exhibited shortness of breath, sports reduction, and drowsiness.
The mouse exhibited symptoms of shortness of breath, tetany, bleeding from mouth and nose, and death.